These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 6416054

  • 21. Evaluation of ristocetin-Willebrand factor assay and ristocetin-induced platelet aggregation.
    Olson JD, Brockway WJ, Fass DN, Magnuson MA, Bowie EJ.
    Am J Clin Pathol; 1975 Feb; 63(2):210-8. PubMed ID: 1078748
    [Abstract] [Full Text] [Related]

  • 22. Dissociation between factor VIII (activity and antigen) and ristocetin-induced platelet aggregation in von Willebrand's disease.
    Barbui T, Dini E.
    Acta Haematol; 1975 Feb; 53(1):44-8. PubMed ID: 807074
    [Abstract] [Full Text] [Related]

  • 23. Gel filtration patterns of factor VIII coagulant antigen and factor VIII related antigen in normal and von Willebrand's disease.
    Chediak J, Peake I, Bloom A.
    Thromb Haemost; 1983 Aug 30; 50(2):509-12. PubMed ID: 6415844
    [Abstract] [Full Text] [Related]

  • 24. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease.
    Ruggeri ZM, Pareti FI, Mannucci PM, Ciavarella N, Zimmerman TS.
    N Engl J Med; 1980 May 08; 302(19):1047-51. PubMed ID: 6767976
    [Abstract] [Full Text] [Related]

  • 25. Ristocetin in the diagnosis of von willebrand's disease: a comparison of rate and percent of aggregation with levels of the plasma factor(s) necessary for ristocetin aggregation.
    Dowling SV, Muntz RH, D'Souza S, Ekert H.
    Thromb Diath Haemorrh; 1975 Nov 15; 34(2):465-74. PubMed ID: 1081746
    [Abstract] [Full Text] [Related]

  • 26. von Willebrand's disease characterized by increased ristocetin sensitivity and the presence of all von Willebrand factor multimers in plasma.
    Holmberg L, Berntorp E, Donnér M, Nilsson IM.
    Blood; 1986 Sep 15; 68(3):668-72. PubMed ID: 3488775
    [Abstract] [Full Text] [Related]

  • 27. Von Willebrand factor multimer patterns in von Willebrand's disease.
    Hoyer LW, Rizza CR, Tuddenham EG, Carta CA, Armitage H, Rotblat F.
    Br J Haematol; 1983 Nov 15; 55(3):493-507. PubMed ID: 6416288
    [Abstract] [Full Text] [Related]

  • 28. Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets.
    Ruggeri ZM, Zimmerman TS.
    J Clin Invest; 1980 Jun 15; 65(6):1318-25. PubMed ID: 6773982
    [Abstract] [Full Text] [Related]

  • 29. Abnormality of glycoprotein Ib in two cases of "pseudo"-von Willebrand's disease.
    Bryckaert MC, Pietu G, Ruan C, Tobelem G, Girma JP, Meyer D, Larrieu MJ, Caen JP.
    J Lab Clin Med; 1985 Oct 15; 106(4):393-400. PubMed ID: 2931492
    [Abstract] [Full Text] [Related]

  • 30. Electrophoretic heterogeneity of normal factor VIII/Von Willebrand protein, and abnormal electrophoretic mobility in patients with Von Willebrand's disease.
    Sultan Y, Simeon J, Caen JP.
    J Lab Clin Med; 1976 Feb 15; 87(2):185-94. PubMed ID: 1082003
    [Abstract] [Full Text] [Related]

  • 31. Factor VIII/von Willebrand factor binding to von Willebrand's disease platelets.
    Gralnick HR, Williams SB, Shafer BC, Corash L.
    Blood; 1982 Aug 15; 60(2):328-32. PubMed ID: 6807372
    [Abstract] [Full Text] [Related]

  • 32. Acquired von Willebrand syndrome with inhibitors both to factor VIII clotting activity and ristocetin-induced platelet aggregation.
    Stableforth P, Tamagnini GL, Dormandy KM.
    Br J Haematol; 1976 Aug 15; 33(4):565-73. PubMed ID: 1087568
    [Abstract] [Full Text] [Related]

  • 33. Platelet-bound ristocetin aggregation factor in normal subjects and patients with von Willebrand's disease.
    Green D, Potter EV.
    J Lab Clin Med; 1976 Jun 15; 87(6):976-86. PubMed ID: 778313
    [Abstract] [Full Text] [Related]

  • 34. Abnormalities of factor VIII and platelet aggregation--use of ristocetin in diagnosing the von Willebrand syndrome.
    Weiss HJ.
    Blood; 1975 Mar 15; 45(3):403-12. PubMed ID: 1078779
    [Abstract] [Full Text] [Related]

  • 35. Family studies of patients with reduced ristocetin aggregation and abnormalities of factor VIII and/or platelet function.
    Ekert H, Ananthakrishnan R, Muntz RH, Dowling S, D'Souza S.
    Thromb Haemost; 1976 Aug 31; 36(1):78-85. PubMed ID: 1087478
    [Abstract] [Full Text] [Related]

  • 36. Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand's disease.
    Jenkins CS, Phillips DR, Clemetson KJ, Meyer D, Larrieu MJ, Lüscher EF.
    J Clin Invest; 1976 Jan 31; 57(1):112-24. PubMed ID: 1081991
    [Abstract] [Full Text] [Related]

  • 37. Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease.
    Weiss HJ, Sussman II, Hoyer LW.
    J Clin Invest; 1977 Aug 31; 60(2):390-404. PubMed ID: 17621
    [Abstract] [Full Text] [Related]

  • 38. Acquired von Willebrand's disease in association with Wilm's tumor: regression following treatment.
    Scott JP, Montgomery RR, Tubergen DG, Hays T.
    Blood; 1981 Oct 31; 58(4):665-9. PubMed ID: 6268230
    [Abstract] [Full Text] [Related]

  • 39. Acquired von Willebrand's syndrome due to an inhibitor of IgG specific for von Willebrand's factor in polycythemia rubra vera.
    Mohri H, Ohkubo T.
    Acta Haematol; 1987 Oct 31; 78(4):258-64. PubMed ID: 3122493
    [Abstract] [Full Text] [Related]

  • 40. Studies of the human factor VIII/von Willebrand factor protein. III. Qualitative defects in von Willebrand's disease.
    Gralnick HR, Coller BS, Sultan Y.
    J Clin Invest; 1975 Oct 31; 56(4):814-27. PubMed ID: 1080491
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.